VRIJE UNIVERSITEIT has a total of 11 patent applications. Its first patent ever was published in 1992. It filed its patents most often in Netherlands, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, medical technology and organic fine chemistry are BIOGEND THERAPEUTICS CO LTD, Beijing sihuan pharmaceutical co ltd and DESMOS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Netherlands | 3 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Australia | 2 | |
#4 | China | 1 | |
#5 | EPO (European Patent Office) | 1 | |
#6 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Organic fine chemistry | |
#4 | Biotechnology | |
#5 | Measurement | |
#6 | Basic materials chemistry | |
#7 | Machines |
# | Name | Total Patents |
---|---|---|
#1 | Burger Elisabeth Henriette | 3 |
#2 | Menge Wiro Michael Petrus Bern | 3 |
#3 | Vollinga Roelant Christiaan | 2 |
#4 | Klein Christel Patrice Anita T | 2 |
#5 | Timmerman Hendrik | 2 |
#6 | Nulend Jenneke Klein | 2 |
#7 | Casarosa Paola | 1 |
#8 | Klein Nulend Jenneke | 1 |
#9 | Hamers Raymond | 1 |
#10 | Ronald Koes | 1 |
Publication | Filing date | Title |
---|---|---|
EP1393728A1 | Inverse agonists acting at virus-encoded G protein-coupled receptors | |
NL1008582C2 | Bone material. | |
WO9506037A1 | New imidazole derivatives having agonistic or antagonistic activity on the histamine h3 receptor | |
NL9302045A | New imidazole derivative with agonistic or antagonistic activity on the histamine H3 receptor | |
NL9201831A | Histidine derivatives |